EGFR and non-small cell lung carcinoma: Another study of 524 patients with NSCLC also found that the rate of EGFR mutation vary with smoking status and histological subtypes, EGFR being the most frequently altered gene in nonsmoking adenocarcinoma patients (An et al., 2012).